Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations (Q38336102)

2 September 2017

1 reference

title

Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations (English)

1 reference

2 September 2017

6

Michele Emdin

1 reference

2 September 2017

Iacopo Olivotto

1

1 reference

2 September 2017

Giulia d'Amati

2

1 reference

2 September 2017

Cristina Basso

3

1 reference

2 September 2017

Albert Van Rossum

4

1 reference

2 September 2017

Monica Patten

5

1 reference

2 September 2017

Yigal Pinto

7

1 reference

2 September 2017

Benedetta Tomberli

8

1 reference

2 September 2017

Paolo G Camici

9

1 reference

2 September 2017

Michelle Michels

10

1 reference

2 September 2017

28 January 2015

1 reference

2 September 2017

Cardiovascular Research

1 reference

2 September 2017

105

1 reference

2 September 2017

4

1 reference

2 September 2017

409-423

1 reference

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

2 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Inherited Cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Mechanical and energetic consequences of HCM-causing mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Genetic advances in sarcomeric cardiomyopathies: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Molecular diagnostics of cardiomyopathies: the future is here.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Genetics of restrictive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Clinical profile and outcome of idiopathic restrictive cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Genetic mutations and mechanisms in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Truncations of titin causing dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Different types of cardiomyopathy associated with isolated ventricular noncompaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Left ventricular noncompaction: a 25-year odyssey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Mutations in sarcomere protein genes in left ventricular noncompaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Coronary microvascular dysfunction: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Twenty years of progress and beckoning frontiers in cardiovascular pathology: cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Dilated cardiomyopathy: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Conduction abnormalities in pediatric patients with restrictive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Stress testing in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Left ventricular solid body rotation in non-compaction cardiomyopathy: a potential new objective and quantitative functional diagnostic criterion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Cardiomyopathies: focus on cardiovascular magnetic resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

The clinical value of myocardial blood flow measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Coronary microvascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

The coronary circulation and blood flow in left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Analysis of circulating apoptosis mediators and proinflammatory cytokines in patients with idiopathic hypertrophic cardiomyopathy: comparison between nonobstructive and dilated-phase hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Heart failure biomarkers in patients with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Long-Term Outcome and Risk Stratification in Dilated Cardiolaminopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV024

21 January 2018

Identifiers

DOI

10.1093/CVR/CVV024

1 reference

2 September 2017

1 reference